Granikal 1mg Injection
Marketer
Kalmia Healthcare
Salt Composition
Granisetron (1mg)
Overview Granikal 1mg Injection
Emesis control is provided by the antiemetic Granikal 1mg Injection, frequently employed to manage postoperative nausea and vomiting, as well as that stemming from cancer treatments like chemotherapy or radiation. Granikal 1mg Injection does not address other cancer therapy side effects. Administered by a healthcare provider, injections should continue as directed until medically discontinued. Following this, oral medication may be prescribed. Commonly reported side effects include injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue. These generally resolve upon cessation of treatment; however, persistent or bothersome symptoms warrant consultation with your physician for management strategies. Prior to commencing treatment, disclose any pre-existing heart or liver conditions, gastrointestinal obstructions, or current medications (particularly those for epilepsy, cardiac issues, cancer, or depression) to your physician, as interactions are possible. Pregnant or breastfeeding individuals should seek medical guidance.
Uses of Granikal 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Granikal 1mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Granikal 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Granikal 1mg Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
How Granikal 1mg Injection works:
Granikal 1mg Injection, an antiemetic, counteracts nausea and vomiting by inhibiting the effects of serotonin, a neurotransmitter in the brain that triggers these symptoms during chemotherapy or post-surgery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Granikal 1mg Injection may pose safety risks; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable medication Granikal, 1mg dose, is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Granikal 1mg Injection safely. Available evidence from human studies indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Granikal 1mg Injection.
KidneySAFE IF PRESCRIBED
Granikal 1mg Injection appears to be safely administered to individuals with kidney impairment. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Granikal 1mg Injection appears safe for use in individuals with hepatic impairment. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Granikal 1mg Injection :
Should you forget a Granikal 1mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Granikal 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |
3,018 People bought this recently